Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study

Sung Woo Ahn, Ji Hyun Baek, Soyung Yang, Yongkang Kim, Youngah Cho, Yujin Choi, Kounseok Lee, Taesung Park, Kyung Sue HongInternational Journal of Bipolar Disorders 2017 · DOI

TL;DR

This study investigated long-term mood stabilizer treatment response in bipolar disorder (BD) patients, finding that psychotic features, mixed episodes, and comorbid anxiety disorders are associated with poorer outcomes. While lithium and valproate showed similar efficacy, patients with poorer responses tended to use multiple medications.

What Problem Does This Paper Address?

Bipolar disorder (BD) is a chronic condition with diverse clinical presentations and treatment responses. While guidelines exist for acute treatment, understanding long-term treatment effectiveness and the factors influencing it in real-world clinical settings remains challenging. Previous research has often focused on single mood stabilizers or specific patient groups, leaving a gap in our understanding of how common mood stabilizers like lithium and valproate perform over extended periods and what clinical characteristics predict success or failure. This paper aims to address this by retrospectively evaluating long-term response to lithium and/or valproate in BD patients and identifying associated clinical correlates.

Methods

The researchers conducted a retrospective observational study on 80 patients diagnosed with bipolar I or II disorder who had been treated with lithium and/or valproate for at least two years. Long-term treatment response was assessed using the Alda scale, a validated tool for retrospective evaluation of prophylactic lithium response, adapted here for broader mood stabilizer use. Clinical characteristics were gathered through chart review and patient interviews, covering lifetime history of mood episodes, symptoms, and comorbidities. Patients were categorized into "good responders" (Alda score ≥ 5) and "moderate/poor responders" (Alda score ≤ 4) using a frequentist mixture analysis. Statistical analyses, including chi-square tests and t-tests, were used to compare demographic and clinical variables between these groups.

Datasets

The study utilized data from 80 patients treated at the Bipolar Disorder Clinic of Samsung Medical Center between March 2009 and April 2015. A subset of 60 patients had previously undergone comprehensive disease characteristic evaluations. No new datasets were introduced.

Key Insights and Ideas

  • Beyond Single Drugs: The study highlights the importance of looking at long-term treatment outcomes in a broader context, considering not just individual drugs but also the complex interplay of medications and clinical factors in real-world BD management.
  • Predictors of Poor Response: The findings underscore that certain clinical features are significant red flags for poorer long-term outcomes. This knowledge can help clinicians anticipate challenges and tailor treatment strategies.
  • Atypical Symptoms Matter: The identification of increased appetite during depressive episodes and delusions during manic episodes as novel predictors of poorer response is a significant contribution, suggesting that even seemingly minor symptoms can have prognostic value.
  • Anxiety as a Key Comorbidity: The strong association between comorbid anxiety disorders and poorer response in this study reinforces the need to address anxiety symptoms comprehensively in BD treatment.

Key Results

  • Response Rate: Approximately one-third (33.8%) of the patients were classified as good responders (Alda score ≥ 5).
  • Drug Efficacy: Lithium and valproate showed similar long-term efficacy when used individually. However, combination therapy with lithium and valproate was associated with poorer response.
  • Predictors of Poorer Response:
    • A higher number of previous mixed episodes was significantly associated with worse response (p = 0.026).
  • Delusions during manic episodes were more common in moderate/poor responders (p = 0.008).
  • Increased appetite during depressive episodes was also more frequent in moderate/poor responders (p = 0.035).
  • Comorbid anxiety disorders were observed exclusively in the moderate/poor response group (p = 0.008).
  • Polypharmacy: Moderate/poor responders were more likely to use multiple adjunct medications, including antipsychotics and antidepressants.

Limitations and Future Work

The authors acknowledge several limitations:

  • Sample Size: The relatively small sample size may limit the statistical power to detect smaller differences, particularly between lithium and valproate users.
  • Retrospective Design: The retrospective nature of the study means a definitive causal relationship between clinical factors and poor response cannot be established.
  • Confounding Variables: Numerous uncontrolled confounding variables inherent in observational studies (e.g., medication dose, plasma levels, non-pharmacologic treatments) could affect the results.
  • Longitudinal Metrics: The study did not use classical longitudinal illness metrics like time to recurrence, which could limit direct comparison with other studies.
  • Generalizability: As the study population was exclusively Korean, the findings may have limited generalizability to other ethnic groups.

Future work could involve prospective studies with larger, more diverse populations to confirm these findings and explore the impact of specific medication doses, adjunctive treatments, and non-pharmacologic interventions on long-term outcomes. Further investigation into the role of atypical depressive symptoms as predictors of treatment response is also warranted.

Summary updated

Abstract

Psychotic, mixed, and atypical features of BDs were found to be correlated with long-term treatment outcomes. Lithium and valproate showed similar efficacy but moderate/poor responders preferred to use polypharmacy.
BibTeX
@article{ahn2017long,
  author = {Sung Woo Ahn and Ji Hyun Baek and Soyung Yang and Yongkang Kim and Youngah Cho and Yujin Choi and Kounseok Lee and Taesung Park and Kyung Sue Hong},
  title = {{Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study}},
  journal = {International Journal of Bipolar Disorders},
  year = {2017},
  doi = {10.1186/s40345-017-0093-5},
}
Figure